Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities
Tuesday, February 2, 2021
Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH)
Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH): The antiviral drug remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment